SEELOS THERAPEUTICS, INC.
SEELOS THERAPEUTICS, INC. is a Private limited company (Ltd.) registered in United States under 5490115, and its current status with New York Department of State — Division of Corporations is active. The company was incorporated on 7 February 2019 and lists its registered address as NEW YORK, United States. 3 shareholders are on record for SEELOS THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New York Department of State — Division of Corporations and was last updated on 4 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
3
Three shareholders are currently on record for SEELOS THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Flagship Wealth Advisors, LLC , holding 59.3% — a majority holding — followed by iShares Trust-iShares Core S&P Total U.S. Stock Market ETF at 35%; the remaining 1 shareholder shown holds smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Flagship Wealth Advisors, LLC | 59.3% | New York Department of State — Division of Corporations | |
| iShares Trust-iShares Core S&P Total U.S. Stock Market ETF | 35% | New York Department of State — Division of Corporations | |
| Vermillion & White Wealth Management Group, LLC | 5.7% | New York Department of State — Division of Corporations |
Officers
5
The Chief Communications Officer of SEELOS THERAPEUTICS, INC. currently on record is Anthony Marciano; five officers are currently on record for SEELOS THERAPEUTICS, INC., filed with New York Department of State — Division of Corporations.
The register reports 6 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at SEELOS THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
SEELOS THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 4 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
SEELOS THERAPEUTICS, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns SEELOS THERAPEUTICS, INC.?
Three shareholders are currently on record for SEELOS THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Flagship Wealth Advisors, LLC , holding 59.3% — a majority holding — followed by iShares Trust-iShares Core S&P Total U.S. Stock Market ETF at 35%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is SEELOS THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for SEELOS THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does SEELOS THERAPEUTICS, INC. have on record?
3 shareholders are shown on record for SEELOS THERAPEUTICS, INC..
What is SEELOS THERAPEUTICS, INC.'s company registration number?
SEELOS THERAPEUTICS, INC.'s registration number is 5490115, filed with New York Department of State — Division of Corporations in United States. Its current status on the register is active.
Is SEELOS THERAPEUTICS, INC. still an active company?
SEELOS THERAPEUTICS, INC.'s status on New York Department of State — Division of Corporations is listed as active.
When was SEELOS THERAPEUTICS, INC. incorporated?
SEELOS THERAPEUTICS, INC. was incorporated on 7 February 2019, according to New York Department of State — Division of Corporations.
What is SEELOS THERAPEUTICS, INC.'s registered address?
The registered address on file for SEELOS THERAPEUTICS, INC. is NEW YORK, United States.
What legal structure is SEELOS THERAPEUTICS, INC. registered as?
SEELOS THERAPEUTICS, INC. is registered as a Private limited company (Ltd.) in United States.
Who are the officers/directors of SEELOS THERAPEUTICS, INC.?
The Chief Communications Officer of SEELOS THERAPEUTICS, INC. currently on record is Anthony Marciano; five officers are currently on record for SEELOS THERAPEUTICS, INC., filed with New York Department of State — Division of Corporations. Management authority at SEELOS THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does SEELOS THERAPEUTICS, INC. have a parent company or subsidiaries?
SEELOS THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 1 jurisdiction. Those 4 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to SEELOS THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from New York Department of State — Division of Corporations. Zavia's monitoring API can track changes to SEELOS THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access SEELOS THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like SEELOS THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from New York Department of State — Division of Corporations and was last synced on 4 October 2026.